Drug profile · INN
osilodrostat phosphate
ISTURISA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
osilodrostat phosphate (ISTURISA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN osilodrostat phosphate
Brand ISTURISA
Route ORAL
Formulation TABLET
Frequently asked questions
What is osilodrostat phosphate?
osilodrostat phosphate (ISTURISA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for osilodrostat phosphate?
ISTURISA is a marketed brand name for osilodrostat phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of osilodrostat phosphate?
osilodrostat phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.